China Neurological Disorder Drugs Market Research Report 2017

Market: Pharma & Healthcare

, 104 pages report, published by QYResearch

Report ThumbnailFebruary-2017
Notes:
Sales, means the sales volume of Neurological Disorder Drugs
Revenue, means the sales value of Neurological Disorder Drugs

This report studies Neurological Disorder Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Novartis AG
GlaxoSmithKline plc
Merck & Co.
Bayer AG
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
Split by Application, this report focuses on consumption, market share and growth rate of Neurological Disorder Drugs in each application, can be divided into
Hospital
Clinic
Home

  • List of Tables and Figures
  • Figure Picture of Neurological Disorder Drugs
  • Figure China Production Market Share of Neurological Disorder Drugs by Type in 2015
  • Figure Product Picture of Antipsychotic
  • Table Major Manufacturers of Antipsychotic
  • Figure Product Picture of Hypnotic & Sedative
  • Table Major Manufacturers of Hypnotic & Sedative
  • Figure Product Picture of Analgesics
  • Table Major Manufacturers of Analgesics
  • Figure Product Picture of Anticoagulants
  • Table Major Manufacturers of Anticoagulants
  • Figure Product Picture of Others
  • Table Major Manufacturers of Others
  • Table Neurological Disorder Drugs Consumption Market Share by Application in 2015
  • Figure Hospital Examples
  • Figure Clinic Examples
  • Figure Home Examples
  • Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2011-2021)
  • Table China Neurological Disorder Drugs Capacity of Key Manufacturers (2015 and 2016)
  • Table China Neurological Disorder Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
  • Figure China Neurological Disorder Drugs Capacity of Key Manufacturers in 2015
  • Figure China Neurological Disorder Drugs Capacity of Key Manufacturers in 2016
  • Table China Neurological Disorder Drugs Production of Key Manufacturers (2015 and 2016)
  • Table China Neurological Disorder Drugs Production Share by Manufacturers (2015 and 2016)
  • Figure 2015 Neurological Disorder Drugs Production Share by Manufacturers
  • Figure 2016 Neurological Disorder Drugs Production Share by Manufacturers
  • Table China Neurological Disorder Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
  • Table China Neurological Disorder Drugs Revenue Share by Manufacturers (2015 and 2016)
  • Table 2015 China Neurological Disorder Drugs Revenue Share by Manufacturers
  • Table 2016 China Neurological Disorder Drugs Revenue Share by Manufacturers
  • Table China Market Neurological Disorder Drugs Average Price of Key Manufacturers (2015 and 2016)
  • Figure China Market Neurological Disorder Drugs Average Price of Key Manufacturers in 2015
  • Table Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution and Sales Area
  • Table Manufacturers Neurological Disorder Drugs Product Type
  • Figure Neurological Disorder Drugs Market Share of Top 3 Manufacturers
  • Figure Neurological Disorder Drugs Market Share of Top 5 Manufacturers
  • Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Novartis AG Neurological Disorder Drugs Market Share (2011-2016)
  • Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table GlaxoSmithKline plc Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure GlaxoSmithKline plc Neurological Disorder Drugs Market Share (2011-2016)
  • Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Merck & Co. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Merck & Co. Neurological Disorder Drugs Market Share (2011-2016)
  • Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Bayer AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Bayer AG Neurological Disorder Drugs Market Share (2011-2016)
  • Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table AstraZeneca Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure AstraZeneca Neurological Disorder Drugs Market Share (2011-2016)
  • Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Market Share (2011-2016)
  • Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Market Share (2011-2016)
  • Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
  • Figure F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Market Share (2011-2016)
  • Figure China Neurological Disorder Drugs Capacity, Production and Growth (2011-2016)
  • Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth (2011-2016)
  • Table China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
  • Table China Neurological Disorder Drugs Production by Type (2011-2016)
  • Table China Neurological Disorder Drugs Production Share by Type (2011-2016)
  • Figure Production Market Share of Neurological Disorder Drugs by Type (2011-2016)
  • Figure 2015 Production Market Share of Neurological Disorder Drugs by Type
  • Table China Neurological Disorder Drugs Revenue by Type (2011-2016)
  • Table China Neurological Disorder Drugs Revenue Share by Type (2011-2016)
  • Figure Production Revenue Share of Neurological Disorder Drugs by Type (2011-2016)
  • Figure 2015 Revenue Market Share of Neurological Disorder Drugs by Type
  • Table China Neurological Disorder Drugs Price by Type (2011-2016)
  • Figure China Neurological Disorder Drugs Production Growth by Type (2011-2016)
  • Table China Neurological Disorder Drugs Consumption by Application (2011-2016)
  • Table China Neurological Disorder Drugs Consumption Market Share by Application (2011-2016)
  • Figure China Neurological Disorder Drugs Consumption Market Share by Application in 2015
  • Table China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
  • Figure China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
  • Table China Neurological Disorder Drugs Production by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Production Market Share by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Production Value by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Production Value Market Share by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Sales Price by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Consumption by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Consumption Market Share by Regions (Provinces)(2011-2016)
  • Table China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Neurological Disorder Drugs
  • Figure Manufacturing Process Analysis of Neurological Disorder Drugs
  • Figure Neurological Disorder Drugs Industrial Chain Analysis
  • Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
  • Table Major Buyers of Neurological Disorder Drugs
  • Table Distributors/Traders List
  • Figure China Neurological Disorder Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
  • Figure China Neurological Disorder Drugs Revenue and Growth Rate Forecast (2016-2021)
  • Table China Neurological Disorder Drugs Production, Import, Export and Consumption Forecast (2016-2021)
  • Table China Neurological Disorder Drugs Production Forecast by Type (2016-2021)
  • Table China Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)
  • Table China Neurological Disorder Drugs Production Forecast by Regions (Provinces)(2016-2021)
  • Table China Neurological Disorder Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
  • Table China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  • Table of Contents
  • China Neurological Disorder Drugs Market Research Report 2017
  • 1 Neurological Disorder Drugs Market Overview
  • 1.1 Product Overview and Scope of Neurological Disorder Drugs
  • 1.2 Neurological Disorder Drugs Segment by Type
  • 1.2.1 China Production Market Share of Neurological Disorder Drugs Type in 2015
  • 1.2.2 Antipsychotic
  • 1.2.3 Hypnotic & Sedative
  • 1.2.4 Analgesics
  • 1.2.5 Anticoagulants
  • 1.2.6 Others
  • 1.3 Applications of Neurological Disorder Drugs
  • 1.3.1 Neurological Disorder Drugs Consumption Market Share by Application in 2015
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Home
  • 1.4 China Market Size (Value) of Neurological Disorder Drugs (2011-2021)
  • 1.5 China Neurological Disorder Drugs Status and Outlook
  • 1.6 Government Policies
  • 2 China Neurological Disorder Drugs Market Competition by Manufacturers
  • 2.1 China Neurological Disorder Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
  • 2.2 China Neurological Disorder Drugs Revenue and Share by Manufacturers (2015 and 2016)
  • 2.3 China Neurological Disorder Drugs Average Price by Manufacturers (2015 and 2016)
  • 2.4 Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution, Sales Area, Product Type
  • 2.5 Neurological Disorder Drugs Market Competitive Situation and Trends
  • 2.5.1 Neurological Disorder Drugs Market Concentration Rate
  • 2.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 3 China Neurological Disorder Drugs Manufacturers Profiles/Analysis
  • 3.1 Novartis AG
  • 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.1.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.1.2.1 Antipsychotic
  • 3.1.2.2 Hypnotic & Sedative
  • 3.1.3 Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.1.4 Main Business/Business Overview
  • 3.2 GlaxoSmithKline plc
  • 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.2.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.2.2.1 Antipsychotic
  • 3.2.2.2 Hypnotic & Sedative
  • 3.2.3 GlaxoSmithKline plc 104 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.2.4 Main Business/Business Overview
  • 3.3 Merck & Co.
  • 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.3.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.3.2.1 Antipsychotic
  • 3.3.2.2 Hypnotic & Sedative
  • 3.3.3 Merck & Co. 108 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.3.4 Main Business/Business Overview
  • 3.4 Bayer AG
  • 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.4.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.4.2.1 Antipsychotic
  • 3.4.2.2 Hypnotic & Sedative
  • 3.4.3 Bayer AG Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.4.4 Main Business/Business Overview
  • 3.5 AstraZeneca
  • 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.5.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.5.2.1 Antipsychotic
  • 3.5.2.2 Hypnotic & Sedative
  • 3.5.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.5.4 Main Business/Business Overview
  • 3.6 Boehringer Ingelheim GmbH
  • 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.6.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.6.2.1 Antipsychotic
  • 3.6.2.2 Hypnotic & Sedative
  • 3.6.3 Boehringer Ingelheim GmbH Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.6.4 Main Business/Business Overview
  • 3.7 Teva Pharmaceutical Industries Ltd.
  • 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.7.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.7.2.1 Antipsychotic
  • 3.7.2.2 Hypnotic & Sedative
  • 3.7.3 Teva Pharmaceutical Industries Ltd. Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.7.4 Main Business/Business Overview
  • 3.8 F. Hoffmann-La Roche Ltd.
  • 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • 3.8.2 Neurological Disorder Drugs Product Type, Application and Specification
  • 3.8.2.1 Antipsychotic
  • 3.8.2.2 Hypnotic & Sedative
  • 3.8.3 F. Hoffmann-La Roche Ltd. Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  • 3.8.4 Main Business/Business Overview
  • 4 China Neurological Disorder Drugs Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
  • 4.1 China Neurological Disorder Drugs Capacity, Production and Growth (2011-2016)
  • 4.2 China Neurological Disorder Drugs Revenue and Growth (2011-2016)
  • 4.3 China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
  • 5 China Neurological Disorder Drugs Production, Revenue (Value), Price Trend by Type
  • 5.1 China Neurological Disorder Drugs Production and Market Share by Type (2011-2016)
  • 5.2 China Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
  • 5.3 China Neurological Disorder Drugs Price by Type (2011-2016)
  • 5.4 China Neurological Disorder Drugs Production Growth by Type (2011-2016)
  • 6 China Neurological Disorder Drugs Market Analysis by Application
  • 6.1 China Neurological Disorder Drugs Consumption and Market Share by Application (2011-2016)
  • 6.2 China Neurological Disorder Drugs Consumption Growth Rate by Application (2011-2016)
  • 6.3 Market Drivers and Opportunities
  • 6.3.1 Potential Application
  • 6.3.2 Emerging Markets/Countries
  • 7 ChinaNeurological Disorder Drugs Market Analysis by Regions (Provinces)
  • 7.1 China Neurological Disorder Drugs Production, Production Value and Price by Regions (Provinces)(2011-2016)
  • 7.1.1 China Neurological Disorder Drugs Production and Market Share by Regions (Provinces)(2011-2016)
  • 7.1.2 China Neurological Disorder Drugs Production Value and Market Share by Regions (Provinces)(2011-2016)
  • 7.1.3 China Neurological Disorder Drugs Sales Price by Regions (Provinces)(2011-2016)
  • 7.2 China Neurological Disorder Drugs Consumption by Regions (Provinces)(2011-2016)
  • 7.3 China Neurological Disorder Drugs Production, Consumption, Export and Import (2011-2016)
  • 8 Neurological Disorder Drugs Manufacturing Cost Analysis
  • 8.1 Neurological Disorder Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
  • 8.1.4 Market Concentration Rate of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.2.1 Raw Materials
  • 8.2.2 Labor Cost
  • 8.2.3 Manufacturing Expenses
  • 8.3 Manufacturing Process Analysis of Neurological Disorder Drugs
  • 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 9.1 Neurological Disorder Drugs Industrial Chain Analysis
  • 9.2 Upstream Raw Materials Sourcing
  • 9.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
  • 9.4 Downstream Buyers
  • 10 Marketing Strategy Analysis, Distributors/Traders
  • 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
  • 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
  • 10.3 Distributors/Traders List
  • 11 Market Effect Factors Analysis
  • 11.1 Technology Progress/Risk
  • 11.1.1 Substitutes Threat
  • 11.1.2 Technology Progress in Related Industry
  • 11.2 Consumer Needs/Customer Preference Change
  • 11.3 Economic/Political Environmental Change
  • 12 China Neurological Disorder Drugs Market Forecast (2016-2021)
  • 12.1 China Neurological Disorder Drugs Capacity, Production, Revenue Forecast (2016-2021)
  • 12.2 China Neurological Disorder Drugs Production, Import, Export and Consumption Forecast (2016-2021)
  • 12.3 China Neurological Disorder Drugs Production Forecast by Type (2016-2021)
  • 12.4 China Neurological Disorder Drugs Consumption Forecast by Application (2016-2021)
  • 12.5 China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  • 12.5.1 China Neurological Disorder Drugs Production Forecast by Regions (Provinces)(2016-2021)
  • 12.5.2 China Neurological Disorder Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
  • 12.5.3 China Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  • 12.6 Neurological Disorder Drugs Price Forecast (2016-2021)
  • 13 Research Findings and Conclusion
  • 14 Appendix
  • Methodology
  • Analyst Introduction
  • Data Source

Please select a license type

Share

Related Products

QYResearchChina Neurological Disorder Drugs Market Research Report 2017 Product ThumbnailChina Neurological Disorder Drugs Market Research Report 2017 , Industry Report available for $3200Product #: 686552
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved